Asst. Prof. Nazli Caf

Academic Title :

Asst. Prof.

Department	Work location
Department of Dermatology	Liv Ulus in Istanbul

Dr. Nazlı Caf is an Asst. Prof. and Dermatologist at Liv Hospital Ulus in Istanbul. She possesses rich academic and clinical experience in diagnosing and treating various acute and chronic dermatological disorders, alongside providing advanced non-surgical aesthetic and therapeutic solutions.

Education and Academic Qualifications

High School: Uskudar American Academy, 2003-2008
Medical Degree: Istanbul University Cerrahpasa Faculty of Medicine, 2008-2014
Specialization in Dermatology: University of Health Sciences, Haseki Training and Research Hospital

Areas of Interest

Psoriasis
Acne, acne scar, and crater treatments
Rosacea
Urticaria (Hives)
Dermatitis (Eczema)
Skin and Nail Fungi
Hair loss and hair diseases
Dermatological Surgery and Wart Treatments
Cosmetic Dermatology (Botox, Dermal Fillers, Salmon DNA, Mesotherapy)
BroadBand Light (BBL) therapy

Work Experience

Dermatology Specialist, Liv Hospital Ulus in Istanbul (Present)
Faculty Member (Asst. Prof.), Department of Dermatology and Venereology, Istanbul Atlas University (2025-Present)
Dermatology Specialist, Basaksehir Cam and Sakura City Hospital (2022-2024)
Dermatology Specialist, Diyarbakir Dagkapi State Hospital (2021-2022)
Dermatology Resident, University of Health Sciences, Haseki Training and Research Hospital (2017-2020)

Professional Affiliations & Memberships

Member of the Turkish Dermatology Association
Executive Committee Member of the Hair Surgery Working Group under the Turkish Dermatology Association
Alternate Member of the Audit Board of the Skin and Venereal Diseases Association
Secretary General of the 11th International Dermatology and Cosmetology Congress (INDERCOS)

Research & Publications

Association of Treatment Burden With Quality of Life and Distress in Hidradenitis Suppurativa (International Journal of Dermatology, 2026)
The effect of head and neck basal cell carcinoma on body image, quality of life, and Skin Cancer Quality of Life Impact Tool (Medicine, 2025)
The treatment efficacy of 7.5% dapsone gel in papulopustular rosacea: a prospective study (Cutaneous and Ocular Toxicology, 2024)
Evaluation of subclinical atherosclerosis in rosacea patients by flow-mediated dilatation method (Journal of Cosmetic Dermatology, 2023)
The comparison of platelet-rich plasma versus injectable platelet rich fibrin in facial skin rejuvenation (Dermatologic Therapy, 2023)

Visits : 238